Search - tctmd.com

Displaying 81 - 100 of 126

Sort: Relevancy | Date

News Daily News

Abbott Buys St. Jude Medical for $25 Billion, Gaining More Muscle in Cardiovascular Device Arena

Michael O'Riordan

April 29, 2016

News Daily News

La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar

Michael O'Riordan

December 27, 2015

News Daily News

Los Expertos Debaten los Tratamientos basados en las Directrices en Pacientes con Enfermedad Multivaso

L.A. McKeown

November 17, 2015

News Daily News

Experts Debate Merits of Guideline-Directed Care for Patients With Multivessel Disease

L.A. McKeown

November 17, 2015

News Conference News AHA 2015

At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation

L.A. McKeown

November 08, 2015

News Industry News

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

October 26, 2015

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

News Conference News TCT 2015

SYNTAX Analysis: MI-Related Deaths More Common With PCI vs. CABG

October 11, 2015

News Daily News

Short-term Readmission Rates Similar After TAVR vs SAVR

Todd Neale

September 10, 2015

News Daily News

Los Índices de Rehospitalizaciones a Corto Plazo son Similares Post TAVR vs SAVR

Todd Neale

September 10, 2015

News Industry News

HeartWare launches European trial for next-gen MVAD heart pump

July 20, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR

Yael L. Maxwell

July 15, 2015

News Industry News

Blue Light Sets The Beat In Biological Pacemaker

June 22, 2015

News Industry News

First patient enrolled in Pivotal's POMEGA Phase IIa clinical trial with PVT-100

June 04, 2015

News Industry News

First One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival And Low Stroke Rate

May 19, 2015

News Daily News

La Revascularización Híbrida para la Enfermedad Multivaso parece Viable y Segura

December 04, 2014

News Daily News

Hybrid Revascularization for Multivessel Disease Appears Feasible, Safe

December 04, 2014

News Conference News AHA 2014

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

Yael L. Maxwell

November 17, 2014

News Daily News

Previous CABG Limits Success of CTO PCI in Native Coronary Arteries

January 27, 2014

Advertisement

Abbott Buys St. Jude Medical for $25 Billion, Gaining More Muscle in Cardiovascular Device Arena

La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar

Los Expertos Debaten los Tratamientos basados en las Directrices en Pacientes con Enfermedad Multivaso

Experts Debate Merits of Guideline-Directed Care for Patients With Multivessel Disease

At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

Companies With Innovative Technologies Compete in TCT Shark Tank

SYNTAX Analysis: MI-Related Deaths More Common With PCI vs. CABG

Short-term Readmission Rates Similar After TAVR vs SAVR

Los Índices de Rehospitalizaciones a Corto Plazo son Similares Post TAVR vs SAVR

HeartWare launches European trial for next-gen MVAD heart pump

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR

Blue Light Sets The Beat In Biological Pacemaker

First patient enrolled in Pivotal's POMEGA Phase IIa clinical trial with PVT-100

First One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival And Low Stroke Rate

La Revascularización Híbrida para la Enfermedad Multivaso parece Viable y Segura

Hybrid Revascularization for Multivessel Disease Appears Feasible, Safe

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

Previous CABG Limits Success of CTO PCI in Native Coronary Arteries

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content